⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.

BLUEJET - IntraDay Trade Analysis with Live Signals

← Back to List

⭐ Rating: 3.2

Last Updated Time : 19 Sept 26, 08:15 am

Key Parameters

⭐ IntraDay Trade Rating: 3.2

RSI45.5
MACD-5.22
Volume5,67,244
Avg Vol 1Wk7,05,490
Low price325 ₹
High price693 ₹
Current Price576 ₹
DMA 50570 ₹
Show all parameters (20 more)
Stock CodeBLUEJET
Market Cap10,898 Cr.
High / Low693 ₹
Stock P/E46.3
Book Value78.4 ₹
Dividend Yield0.21 %
ROCE26.1 %
ROE19.4 %
Face Value2.00 ₹
DMA 200541 ₹
Chg in FII Hold-0.26 %
Chg in DII Hold4.60 %
PAT Qtr78.3 Cr.
PAT Prev Qtr64.3 Cr.
PEG Ratio3.14
Debt to equity0.03
52w Index68.1 %
Qtr Profit Var-14.2 %
EPS13.5 ₹
Industry PE34.8

🧾 Trade Setup

Optimal buy price: 573 ₹. Initial stop-loss: 560 ₹. Target profit level 1: 585 ₹ (based on immediate volume reaction to news and the positive momentum). Target profit level 2: 595 ₹ (if volume continues to sustain above average weekly levels). Overall, a cautiously optimistic play today based on short-term catalysts – manage risk aggressively.

✅ Positive

The recent EcoVadis Silver Medal award for sustainability is a positive signal, particularly given the increased investor focus on ESG factors today. Furthermore, DII holding has surged by 4.60%, suggesting growing domestic interest and potentially fueling short-term demand.

⚠️ Limitation

Despite the positive news and strong volume, the high P/E ratio of 46.3 compared to the industry average of 34.8 indicates a premium valuation that could limit upside potential if momentum stalls. The MACD is still negative, suggesting continued bearish sentiment and potential for further downside risk.

📈 Company Positive News

Blue Jet Healthcare won an EcoVadis Silver Medal for sustainability which resonates with current investor interest in ESG. Scanx.trade’s alert regarding dividend stocks also adds a layer of support given the stock's yield.

🏭 Industry

The pharmaceutical sector is currently experiencing mixed sentiment due to regulatory uncertainty and competition, but strong earnings growth within Blue Jet Healthcare is somewhat insulated from these broader concerns – this could be amplified by the sustainability award.

Choose Technical Analysis or Fundamental Analysis above to load it.

How BLUEJET Rates Across All Strategies

★ 4.0
Entry Price: 570 ₹.
Intraday
★ 3.2
You're viewing this analysis below.
★ 3.2
An ideal entry price zone would be between 540 ₹ and 570 ₹, capitaliz…
★ 3.2
We are seeing a consolidation phase within the 541-570₹ range, acting…
★ 2.8
We recommend an entry zone around 530-545 ₹, based on the current val…

NIFTY 50 · Intraday Trading

NEXT 50 · Intraday Trading

MIDCAP · Intraday Trading

SMALLCAP · Intraday Trading